Terumo (OTC:TRUMY;TYO:4543) subsidiary MicroVention said today that it won pre-market approval from the FDA for the Web brain aneurysm device it acquired when it bought Sequent Medical back in 2016. Aliso Viejo, Calif.-based MicroVention said the PMA for the Web embolic coil covers the treatment of intracranial wide neck bifurcation aneurysms. “We are proud to offer […]
Terumo closes $280m Sequent Medical buyout
Terumo Corp. (TYO:4543) said today that its MicroVention subsidiary closed the $280 million acquisition of Sequent Medical and its Web aneurysm embolization device. The Web implant is made of a Nitinol mesh that is delivered in a “stent-like” manner and deployed into the pouch formed by an aneurysm in order to prevent blood from flowing in. Sequent […]
Terumo buys Sequent Medical for $280m
Terumo Corp. (TYO:4543) said today it picked up Sequent Medical, developer of the Web aneurysm embolization device, for $280 million. The Web implant is made of a Nitinol mesh that is delivered in a “stent-like” manner and deployed into the pouch formed by an aneurysm in order to prevent blood from flowing in. Sequent won […]
Sequent wins FDA nod to add smaller Web device to IDE trial
Sequent Medical said today it won clearance from the FDA to add its smaller .021″ Web aneurysm embolization system to its investigational device exemption trial. The smaller .021″ version is the latest generation Web device from the Aliso Viejo, Calif.-based company, delivered through a smaller version of its VIA microcatheter. The Web implant is made of a […]
Ex-ConMed exec is Interventional Spine’s new Darling | Personnel Moves
Interventional Spine said it has tagged ex-ConMed executive and 25-year medical veteran Joseph Darling as its new vice president and COO. Darling spent 7 years with ConMed, serving as the COO, executive veep and prez of ConMed Linvatec until February this year. Before his time at ConMed, Darling worked with Smith & Nephew, Wyeth-Ayerst Pharmaceuticals, Baxter […]
Sequent Medical CEO Wilder bets on MicroBraids
Sequent launches U.S. clinical trial of brain aneurysm device
Medtech company Sequent Medical enrolled the 1st 4 patients in a new U.S. clinical trial aimed at winning FDA approval for its Web aneurysm protection implant.
The Web implant is made of a Nitinol mesh that is delivered in a "stent-like" manner and deployed into the pouch formed by an aneurysm in order to prevent blood from flowing in. The device already has approve in the European Union.
DOD hands out $99.6 million in contracts to Hologic, GE, PositiveID | Medtech funding stories for the week of Apr. 7, 2014
Sequent Medical raises $20M Series D for brain aneurysm device
Sequent Medical said it raised a Series D round worth $20 million from its slate of previous investors, led again by Delphi Ventures.
Domain Associates, US Venture Partners and Versant Ventures also participated, Sequent said.
St. Jude Medical rebounds after “Greek tragedy” | Wall Street Beat
Shares of St. Jude Medical (NYSE:STJ) clawed back some of the value lost yesterday in what 1 waggish analyst termed a “Greek tragedy.”
STJ shares closed down 3.3% yesterday at $39.96 when the company revealed a $56 million writedown after a Greek distributor failed to pay up for an estimated 2 years worth of sales.
MassDevice Network
@MassDevice
LinkedIn
YouTube